Statistici de bază
| CIK | 1039466 |
SEC Filings
All companies that sell securities in the United States must register with the Securities and Exchange Commission (SEC) and file reports on a regular basis.
These reports include company annual reports (10K, 10Q), news updates (8K), investor presentations (found in 8Ks), insider trades (form 4), ownership reports (13D, and 13G), and reports related to the specific securities sold, such as registration statements and prospectus. This page shows recent SEC filings related to NovAccess Global Inc.
SEC Filings (Chronological Order)
Această pagină oferă o listă completă, cronologică, a dosarelor SEC, cu excepția dosarelor de proprietate pe care le oferim în altă parte.
| January 14, 2026 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended September 30, 2024 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission file number: 000-29621 NovAccess Global Inc. (Exact name of registrant as specifi |
|
| November 18, 2024 |
EX-99 2 ex99-1.htm JOINT FILING AGREEMENT Exhibit 99.1 JOINT FILING AGREEMENT In accordance with Rule 13d-1(k) promulgated under the Securities Exchange Act of 1934, as amended, the undersigned hereby agree to the joint filing with all other reporting persons (as such term is used in the Schedule 13G referred to below) on behalf of each of them of a statement on Schedule 13G (including amendments |
|
| November 18, 2024 |
SC 13G/A 1 sc13g.htm SCHEDULE 13G AMENDMENT NO. 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 4)* NOVACCESS GLOBAL, INC. (Name of Issuer) Common Stock, no par value (Title of Class of Securities) 67001N107 (CUSIP Number) August 16, 2024 (Date of Event Which Requires Filing of this Statement) Check the |
|
| October 31, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2024 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission file number: 000-29621 NovAccess Global Inc. (Exact name of registrant as spec |
|
| September 24, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 September 18, 2024 (Date of earliest event reported) NovAccess Global Inc. |
|
| September 24, 2024 |
Exhibit 10.1 SECURITIES PURCHASE AGREEMENT This SECURITIES PURCHASE AGREEMENT (the “Agreement”), dated as of September 18, 2024, by and between NOVACCESS GLOBAL INC., a Colorado corporation, with headquarters located at 8584 E. Washington Street, No. 127, Chagrin Falls, Ohio 44023 (the “Company”), and AJB CAPITAL INVESTMENTS, LLC, a Delaware limited liability company, with its address at 2455 Holl |
|
| September 24, 2024 |
Exhibit 10.4 REGISTRATION RIGHTS AGREEMENT This REGISTRATION RIGHTS AGREEMENT (the “Agreement”), dated as of September 18, 2024, by and between NOVACCESS GLOBAL INC., a Colorado corporation, with headquarters located at 8584 E. Washington Street, No. 127, Chagrin Falls, Ohio 44023 (the “Company”), and AJB CAPITAL INVESTMENTS, LLC, a Delaware limited liability company, with offices at 2455 Hollywoo |
|
| September 24, 2024 |
Exhibit 10.3 FOURTH AMENDMENT TO SECURITY AGREEMENT This FOURTH AMENDMENT TO SECURITY AGREEMENT (the “Amendment”) is dated effective as of the September 18, 2024 (the “Amendment Effective Date”), by and between Novaccess Global Inc., a Colorado corporation (the “Company”) and AJB Capital Investments, LLC, a Delaware limited liability company (“AJB” and together with the Company, the “Parties”). RE |
|
| September 24, 2024 |
Exhibit 10.5 NEITHER THIS SECURITY NOR THE SECURITIES AS TO WHICH THIS SECURITY MAY BE EXERCISED HAVE BEEN REGISTERED WITH THE SECURITIES AND EXCHANGE COMMISSION OR THE SECURITIES COMMISSION OF ANY STATE IN RELIANCE UPON AN EXEMPTION FROM REGISTRATION UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”), AND, ACCORDINGLY, MAY NOT BE OFFERED OR SOLD EXCEPT PURSUANT TO AN EFFECTIVE RE |
|
| September 24, 2024 |
Exhibit 10.2 NEITHER THE ISSUANCE AND SALE OF THE SECURITIES REPRESENTED BY THIS CERTIFICATE NOR THE SECURITIES INTO WHICH THESE SECURITIES ARE CONVERTIBLE HAVE BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR APPLICABLE STATE SECURITIES LAWS. THE SECURITIES MAY NOT BE OFFERED FOR SALE, SOLD, TRANSFERRED OR ASSIGNED (I) IN THE ABSENCE OF (A) AN EFFECTIVE REGISTRATION STATEMENT FOR |
|
| August 1, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 July 26, 2024 (Date of earliest event reported) NovAccess Global Inc. |
|
| June 11, 2024 |
XSNX / NovAccess Global Inc. / Sumner David - SCHEDULE 13D Activist Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington D.C. 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 (Amendment No. ) NovAccess Global Inc. (Name of Issuer) Common Stock, no par value per share (Title of Class of Securities) 98385L 10 2 (CUSIP Number) Christopher J. Hubbert 1375 East Ninth Street, 29th Floor Cleveland, Ohio 44114 216-736-7215 (Name, Address and Telephone N |
|
| June 4, 2024 |
Exhibit 10.1 Interest Free Convertible Loan Agreement This Interest Free Convertible Loan Agreement (this “Agreement”) is entered into as of May 31, 2024 (the “Effective Date”) by and between NovAccess Global Inc., a Colorado corporation (“NovAccess”), and John A. Cassarini (“Cassarini”). Whereas, NovAccess is currently seeking financing to fund its operations and repay debt, but requires a short- |
|
| June 4, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 May 31, 2024 (Date of earliest event reported) NovAccess Global Inc. |
|
| May 17, 2024 |
Exhibit 10.5 NEITHER THIS SECURITY NOR THE SECURITIES AS TO WHICH THIS SECURITY MAY BE EXERCISED HAVE BEEN REGISTERED WITH THE SECURITIES AND EXCHANGE COMMISSION OR THE SECURITIES COMMISSION OF ANY STATE IN RELIANCE UPON AN EXEMPTION FROM REGISTRATION UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”), AND, ACCORDINGLY, MAY NOT BE OFFERED OR SOLD EXCEPT PURSUANT TO AN EFFECTIVE RE |
|
| May 17, 2024 |
Exhibit 10.4 REGISTRATION RIGHTS AGREEMENT This REGISTRATION RIGHTS AGREEMENT (the “Agreement”), dated as of May 13, 2024, by and between NOVACCESS GLOBAL INC., a Colorado corporation, with headquarters located at 8584 E. Washington Street, No. 127, Chagrin Falls, Ohio 44023 (the “Company”), and AJB CAPITAL INVESTMENTS, LLC, a Delaware limited liability company, with offices at 4700 Sheridan Stree |
|
| May 17, 2024 |
Exhibit 10.2 NEITHER THE ISSUANCE AND SALE OF THE SECURITIES REPRESENTED BY THIS CERTIFICATE NOR THE SECURITIES INTO WHICH THESE SECURITIES ARE CONVERTIBLE HAVE BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR APPLICABLE STATE SECURITIES LAWS. THE SECURITIES MAY NOT BE OFFERED FOR SALE, SOLD, TRANSFERRED OR ASSIGNED (I) IN THE ABSENCE OF (A) AN EFFECTIVE REGISTRATION STATEMENT FOR |
|
| May 17, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 May 13, 2024 (Date of earliest event reported) NovAccess Global Inc. |
|
| May 17, 2024 |
Exhibit 10.6 NEITHER THIS SECURITY NOR THE SECURITIES AS TO WHICH THIS SECURITY MAY BE EXERCISED HAVE BEEN REGISTERED WITH THE SECURITIES AND EXCHANGE COMMISSION OR THE SECURITIES COMMISSION OF ANY STATE IN RELIANCE UPON AN EXEMPTION FROM REGISTRATION UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”), AND, ACCORDINGLY, MAY NOT BE OFFERED OR SOLD EXCEPT PURSUANT TO AN EFFECTIVE RE |
|
| May 17, 2024 |
Exhibit 10.7 Stock Purchase Agreement This Stock Purchase Agreement (this “Agreement”) is entered into effective 17 May 2024 (the “Effective Date”) by NovAccess Global Inc., a Colorado corporation (“Buyer”), and Dawn Digital Limited, a special purpose holding company incorporated in the British Virgin Islands (“Seller”). Recitals A. Seller owns ordinary capital shares, £0.001 per share (the “Stock |
|
| May 17, 2024 |
Exhibit 10.1 SECURITIES PURCHASE AGREEMENT This SECURITIES PURCHASE AGREEMENT (the “Agreement”), dated as of May 13, 2024, by and between NOVACCESS GLOBAL INC., a Colorado corporation, with headquarters located at 8584 E. Washington Street, No. 127, Chagrin Falls, Ohio 44023 (the “Company”), and AJB CAPITAL INVESTMENTS, LLC, a Delaware limited liability company, with its address at 4700 Sheridan S |
|
| May 17, 2024 |
Exhibit 10.3 SECOND AMENDMENT TO SECURITY AGREEMENT This SECOND AMENDMENT TO SECURITY AGREEMENT (the “Amendment”) is dated effective as of the May 13, 2024 (the “Amendment Effective Date”), by and between Novaccess Global Inc., a Colorado corporation (the “Company”) and AJB Capital Investments, LLC, a Delaware limited liability company (“AJB” and together with the Company, the “Parties”). RECITALS |
|
| May 15, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2024 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission file number: 000-29621 NovAccess Global Inc. (Exact name of registrant as spe |
|
| May 3, 2024 |
NovAccess Global Announces New License to Advance its Immunotherapy Platform Exhibit 99.1 NovAccess Global Announces New License to Advance its Immunotherapy Platform Cleveland, OH — April 30, 2024 — NovAccess Global Inc. (OTCQB: XSNX), a biomedical company developing a novel immunotherapy for patients suffering from cancers of the central nervous system, today announced the procurement of a new intellectual property license from Cedars-Sinai Medical Center to further adva |
|
| May 3, 2024 |
Exhibit 10.3 FIRST AMENDMENT TO SECURITY AGREEMENT This FIRST AMENDMENT TO SECURITY AGREEMENT (the “Amendment”) is dated effective as of the April 29, 2024 (the “Amendment Effective Date”), by and between Novaccess Global Inc., a Colorado corporation (the “Company”) and AJB Capital Investments, LLC, a Delaware limited liability company (“AJB” and together with the Company, the “Parties”). RECITALS |
|
| May 3, 2024 |
Exhibit 10.4 REGISTRATION RIGHTS AGREEMENT This REGISTRATION RIGHTS AGREEMENT (the “Agreement”), dated as of April 29, 2024, by and between NOVACCESS GLOBAL INC., a Colorado corporation, with headquarters located at 8584 E. Washington Street, No. 127, Chagrin Falls, Ohio 44023 (the “Company”), and AJB CAPITAL INVESTMENTS, LLC, a Delaware limited liability company, with offices at 4700 Sheridan Str |
|
| May 3, 2024 |
Exhibit 10.1 SECURITIES PURCHASE AGREEMENT This SECURITIES PURCHASE AGREEMENT (the “Agreement”), dated as of April 29, 2024, by and between NOVACCESS GLOBAL INC., a Colorado corporation, with headquarters located at 8584 E. Washington Street, No. 127, Chagrin Falls, Ohio 44023 (the “Company”), and AJB CAPITAL INVESTMENTS, LLC, a Delaware limited liability company, with its address at 4700 Sheridan |
|
| May 3, 2024 |
Exhibit 10.2 NEITHER THE ISSUANCE AND SALE OF THE SECURITIES REPRESENTED BY THIS CERTIFICATE NOR THE SECURITIES INTO WHICH THESE SECURITIES ARE CONVERTIBLE HAVE BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR APPLICABLE STATE SECURITIES LAWS. THE SECURITIES MAY NOT BE OFFERED FOR SALE, SOLD, TRANSFERRED OR ASSIGNED (I) IN THE ABSENCE OF (A) AN EFFECTIVE REGISTRATION STATEMENT FOR |
|
| May 3, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 April 29, 2024 (Date of earliest event reported) NovAccess Global Inc. |
|
| April 26, 2024 |
United States securities and exchange commission logo April 26, 2024 Neil J. Laird Chief Financial Officer NovAccess Global Inc. 8584 E. Washington Street No 127 Chagrin Falls, OH 44023 Re: NovAccess Global Inc. Form 10-K for the Year Ended December 31, 2023 File No 000-29621 Dear Neil J. Laird: We have completed our review of your filing. We remind you that the company and its management are resp |
|
| April 24, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K/A Amendment No. 1 ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended September 30, 2023 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission file number: 000-29621 NovAccess Global Inc. (Exact name of reg |
|
| April 24, 2024 |
NovAccess Global Inc. April 24, 2024 Via EDGAR United States Securities and Exchange Commission Division of Corporate Finance Office of Life Sciences Attention: Christine Torney and Daniel Gordon Re: NovAccess Global Inc. Form 10-K for the Year Ended December 31, 2023 File No 000-29621 Ladies and Gentlemen: Please find below the response of NovAccess Global Inc. (“we,” “our” or the “company”) to t |
|
| April 16, 2024 |
United States securities and exchange commission logo April 16, 2024 Neil J. Laird Chief Financial Officer NovAccess Global Inc. 8584 E. Washington Street No 127 Chagrin Falls, OH 44023 Re: NovAccess Global Inc. Form 10-K for the Year Ended December 31, 2023 File No 000-29621 Dear Neil J. Laird: We have limited our review of your filing to the financial statements and related disclosures and have |
|
| February 28, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 February 27, 2024 (Date of earliest event reported) NovAccess Global Inc. |
|
| February 28, 2024 |
Exhibit 10.2 NEITHER THE ISSUANCE AND SALE OF THE SECURITIES REPRESENTED BY THIS CERTIFICATE NOR THE SECURITIES INTO WHICH THESE SECURITIES ARE CONVERTIBLE HAVE BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR APPLICABLE STATE SECURITIES LAWS. THE SECURITIES MAY NOT BE OFFERED FOR SALE, SOLD, TRANSFERRED OR ASSIGNED (I) IN THE ABSENCE OF (A) AN EFFECTIVE REGISTRATION STATEMENT FOR |
|
| February 28, 2024 |
Exhibit 10.3 SECURITY AGREEMENT This SECURITY AGREEMENT (this “Agreement”) made and effective as of February 27, 2024, is executed by and between NOVACCESS GLOBAL INC., a Colorado corporation, with headquarters located at 8584 E. Washington Street, No. 127, Chagrin Falls, Ohio 44023 (the “Company”), and AJB CAPITAL INVESTMENTS, LLC, a Delaware limited liability company (the “Secured Party”). WHERE |
|
| February 28, 2024 |
Exhibit 10.1 SECURITIES PURCHASE AGREEMENT This SECURITIES PURCHASE AGREEMENT (the “Agreement”), dated as of February 27, 2024, by and between NOVACCESS GLOBAL INC., a Colorado corporation, with headquarters located at 8584 E. Washington Street, No. 127, Chagrin Falls, Ohio 44023 (the “Company”), and AJB CAPITAL INVESTMENTS, LLC, a Delaware limited liability company, with its address at 4700 Sheri |
|
| February 28, 2024 |
Exhibit 10.4 REGISTRATION RIGHTS AGREEMENT This REGISTRATION RIGHTS AGREEMENT (the “Agreement”), dated as of February 27, 2024, by and between NOVACCESS GLOBAL INC., a Colorado corporation, with headquarters located at 8584 E. Washington Street, No. 127, Chagrin Falls, Ohio 44023 (the “Company”), and AJB CAPITAL INVESTMENTS, LLC, a Delaware limited liability company, with offices at 4700 Sheridan |
|
| February 27, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended December 31, 2023 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission file number: 000-29621 NovAccess Global Inc. (Exact name of registrant as |
|
| February 15, 2024 |
SEC FILE NUMBER 000-29621 CUSIP NUMBER 67001N 107 UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D. |
|
| February 9, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended September 30, 2023 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission file number: 000-29621 NovAccess Global Inc. (Exact name of registrant as specifi |
|
| February 6, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 February 1, 2024 (Date of earliest event reported) NovAccess Global Inc. |
|
| January 22, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 January 16, 2024 (Date of earliest event reported) NovAccess Global Inc. |
|
| January 18, 2024 |
XSNX / NovAccess Global Inc. / AJB Capital Investments LLC - SCHEDULE 13G Passive Investment SC 13G 1 sc13g.htm SCHEDULE 13G UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. )* NOVACCESS GLOBAL, INC. (Name of Issuer) Common Stock, no par value (Title of Class of Securities) 67001N107 (CUSIP Number) February 9, 2023 (Date of Event Which Requires Filing of this Statement) Check the appropriate box t |
|
| January 5, 2024 |
Exhibit 10.1 December 29, 2023 NOVACCESS GLOBAL INC. 8584 E. Washington Street, No. 127 Chagrin Falls, OH 44023 Attn: E-mail: VIA ELECTRONIC MAIL Re: Advance and Modifications to Warrants Dear Sirs: Reference is made to (i) those three securities purchase agreements dated August 20, 2021, February 15, 2022, and May 5, 2022 by and between NovAccess Global Inc., a Colorado corporation (the “Company” |
|
| January 5, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 December 29, 2023 (Date of earliest event reported) NovAccess Global Inc. |
|
| January 2, 2024 |
Exhibit 10.1 Securities Purchase Agreement This Securities Purchase Agreement (this “Agreement”), dated as of December 29, 2023 (the “Execution Date”), by and between NovAccess Global Inc., a Colorado corporation (the “Company”), and Sumner Global LLC, a Delaware limited liability company (the “Buyer”). Whereas: A. The Company and the Buyer are executing and delivering this Agreement in reliance u |
|
| January 2, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 December 29, 2023 (Date of earliest event reported) NovAccess Global Inc. |
|
| January 2, 2024 |
Exhibit 99.1 NovAccess Global Announces $10.7 Million Financing Establishes Strong Financial Base To Advance Development of Novel Cancer Immunotherapies Cleveland, OH – January 2, 2024 - NovAccess Global Inc. (OTCQB: XSNX), a biomedical company developing novel immunotherapies for brain tumor patients, today announced it entered into a securities purchase agreement with an affiliate of Sumner Glob |
|
| January 2, 2024 |
SEC FILE NUMBER 000-29621 CUSIP NUMBER 67001N 107 UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D. |
|
| December 21, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 December 21, 2023 (Date of earliest event reported) NovAccess Global Inc. |
|
| September 11, 2023 |
Exhibit 20.1 NovAccess Global Common Stock Offering Term Sheet This term sheet (this “Term Sheet”) summarizes the principal terms of a common stock investment in NovAccess Global Inc., a Colorado corporation. The Company NovAccess Global Inc. (OTCQB: XSNX) Investors Investor group led by the Sumner Investment Group (“SIG”) Common Shares 33,000,000 newly issued shares of the Company’s unregistered |
|
| September 11, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 September 1, 2023 (Date of earliest event reported) NovAccess Global Inc. |
|
| August 18, 2023 |
Exhibit 10.3 SECURITIES PURCHASE AGREEMENT This SECURITIES PURCHASE AGREEMENT (the “Agreement”), dated as of August 17, 2023, by and between NovAccess Global Inc., a Colorado corporation, with its address at 8584 E. Washington St, #127, Chagrin Falls, OH 44023 (the “Company”), and 1800 DIAGONAL LENDING LLC, a Virginia limited liability company, with its address at 1800 Diagonal Road, Suite 623, Al |
|
| August 18, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 August 16, 2023 (Date of earliest event reported) NovAccess Global Inc. |
|
| August 18, 2023 |
Exhibit 10.1 SECURITIES PURCHASE AGREEMENT This SECURITIES PURCHASE AGREEMENT (the “Agreement”), dated as of August 16, 2023, by and between NovAccess Global Inc., a Colorado corporation, with its address at 8584 E. Washington Street #127, Chagrin Falls, Ohio 44023 (the “Company”), and 13 PAUL LENDING LLC, a Virginia limited liability company, with its address at 1322 Hillside Ave, Suite 115, Harr |
|
| August 18, 2023 |
Exhibit 10.2 NEITHER THE ISSUANCE AND SALE OF THE SECURITIES REPRESENTED BY THIS CERTIFICATE NOR THE SECURITIES INTO WHICH THESE SECURITIES ARE CONVERTIBLE HAVE BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR APPLICABLE STATE SECURITIES LAWS. THE SECURITIES MAY NOT BE OFFERED FOR SALE, SOLD, TRANSFERRED OR ASSIGNED IN THE ABSENCE OF (A) AN EFFECTIVE REGISTRATION STATEMENT FOR THE |
|
| August 18, 2023 |
Exhibit 10.4 NEITHER THE ISSUANCE AND SALE OF THE SECURITIES REPRESENTED BY THIS CERTIFICATE NOR THE SECURITIES INTO WHICH THESE SECURITIES ARE CONVERTIBLE HAVE BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR APPLICABLE STATE SECURITIES LAWS. THE SECURITIES MAY NOT BE OFFERED FOR SALE, SOLD, TRANSFERRED OR ASSIGNED IN THE ABSENCE OF (A) AN EFFECTIVE REGISTRATION STATEMENT FOR THE |
|
| August 14, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 August 9, 2023 (Date of earliest event reported) NovAccess Global Inc. |
|
| August 14, 2023 |
Exhibit 10.2 NEITHER THIS SECURITY NOR THE SECURITIES AS TO WHICH THIS SECURITY MAY BE EXERCISED HAVE BEEN REGISTERED WITH THE SECURITIES AND EXCHANGE COMMISSION OR THE SECURITIES COMMISSION OF ANY STATE IN RELIANCE UPON AN EXEMPTION FROM REGISTRATION UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”), AND, ACCORDINGLY, MAY NOT BE OFFERED OR SOLD EXCEPT PURSUANT TO AN EFFECTIVE RE |
|
| August 14, 2023 |
Exhibit 10.1 August 9, 2023 NOVACCESS GLOBAL INC. 8584 E. Washington Street, No. 127 Chagrin Falls, OH 44023 Attn: E-mail: VIA ELECTRONIC MAIL Re: Modifications Dear Sirs: Reference is made to those three securities purchase agreements dated August 20, 2021, February 15, 2022, and May 5, 2022 by and between NovAccess Global Inc., a Colorado corporation (the “Company”), and AJB Capital Investments, |
|
| August 11, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2023 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission file number: 000-29621 NovAccess Global Inc. (Exact name of registrant as spec |
|
| June 30, 2023 |
Exhibit 10.1 SECURITIES PURCHASE AGREEMENT This SECURITIES PURCHASE AGREEMENT (the “Agreement”), dated as of June 20, 2023, by and between NovAccess Global Inc., a Colorado corporation, with its address at 8834 Mayfield Road, Suite C, Chesterland, Ohio 44026 (the “Company”), and 1800 DIAGONAL LENDING LLC, a Virginia limited liability company, with its address at 1800 Diagonal Road, Suite 623, Alex |
|
| June 30, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 June 26, 2023 (Date of earliest event reported) NovAccess Global Inc. |
|
| June 30, 2023 |
Exhibit 10.2 NEITHER THE ISSUANCE AND SALE OF THE SECURITIES REPRESENTED BY THIS CERTIFICATE NOR THE SECURITIES INTO WHICH THESE SECURITIES ARE CONVERTIBLE HAVE BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR APPLICABLE STATE SECURITIES LAWS. THE SECURITIES MAY NOT BE OFFERED FOR SALE, SOLD, TRANSFERRED OR ASSIGNED IN THE ABSENCE OF (A) AN EFFECTIVE REGISTRATION STATEMENT FOR THE |
|
| June 23, 2023 |
Exhibit 10.2 NEITHER THIS SECURITY NOR THE SECURITIES AS TO WHICH THIS SECURITY MAY BE EXERCISED HAVE BEEN REGISTERED WITH THE SECURITIES AND EXCHANGE COMMISSION OR THE SECURITIES COMMISSION OF ANY STATE IN RELIANCE UPON AN EXEMPTION FROM REGISTRATION UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”), AND, ACCORDINGLY, MAY NOT BE OFFERED OR SOLD EXCEPT PURSUANT TO AN EFFECTIVE RE |
|
| June 23, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 June 20, 2023 (Date of earliest event reported) NovAccess Global Inc. |
|
| June 23, 2023 |
Letter Agreement dated June 19, 2023 between NovAccess Global Inc. and AJB Capital Investments, LLC Exhibit 10.1 June 19, 2023 NOVACCESS GLOBAL INC. 8584 E. Washington Street, No. 127 Chagrin Falls, OH 44023 Attn: E-mail: VIA ELECTRONIC MAIL Re: Modifications Dear Sirs: Reference is made to the securities purchase agreements dated May 5, 2022 by and between NovAccess Global Inc., a Colorado corporation (the “Company”), and AJB Capital Investments, LLC, a Delaware limited liability company (the “ |
|
| June 12, 2023 |
Exhibit 10.2 NEITHER THIS SECURITY NOR THE SECURITIES AS TO WHICH THIS SECURITY MAY BE EXERCISED HAVE BEEN REGISTERED WITH THE SECURITIES AND EXCHANGE COMMISSION OR THE SECURITIES COMMISSION OF ANY STATE IN RELIANCE UPON AN EXEMPTION FROM REGISTRATION UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”), AND, ACCORDINGLY, MAY NOT BE OFFERED OR SOLD EXCEPT PURSUANT TO AN EFFECTIVE RE |
|
| June 12, 2023 |
Letter Agreement dated June 8, 2023 between NovAccess Global Inc. and AJB Capital Investments, LLC Exhibit 10.1 June 8, 2023 NOVACCESS GLOBAL INC. 8584 E. Washington Street, No. 127 Chagrin Falls, OH 44023 Attn: E-mail: VIA ELECTRONIC MAIL Re: Modifications Dear Sirs: Reference is made to those three securities purchase agreements dated August 20, 2021, February 15, 2022, and May 5, 2022 by and between NovAccess Global Inc., a Colorado corporation (the “Company”), and AJB Capital Investments, L |
|
| June 12, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 June 8, 2023 (Date of earliest event reported) NovAccess Global Inc. |
|
| May 15, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2023 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission file number: 000-29621 NovAccess Global Inc. (Exact name of registrant as spe |
|
| May 2, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 April 28, 2023 (Date of earliest event reported) NovAccess Global Inc. |
|
| May 2, 2023 |
Exhibit 10.1 SECURITIES PURCHASE AGREEMENT This SECURITIES PURCHASE AGREEMENT (the “Agreement”), dated as of April 24, 2023, by and between NovAccess Global Inc., a Colorado corporation, with its address at 8584 E. Washington Street #127, Chagrin Falls, Ohio 44023 (the “Company”), and 1800 DIAGONAL LENDING LLC, a Virginia limited liability company, with its address at 1800 Diagonal Road, Suite 623 |
|
| May 2, 2023 |
Exhibit 10.2 NEITHER THE ISSUANCE AND SALE OF THE SECURITIES REPRESENTED BY THIS CERTIFICATE NOR THE SECURITIES INTO WHICH THESE SECURITIES ARE CONVERTIBLE HAVE BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR APPLICABLE STATE SECURITIES LAWS. THE SECURITIES MAY NOT BE OFFERED FOR SALE, SOLD, TRANSFERRED OR ASSIGNED IN THE ABSENCE OF (A) AN EFFECTIVE REGISTRATION STATEMENT FOR THE |
|
| April 18, 2023 |
Exhibit 10.1 SECURITIES PURCHASE AGREEMENT This SECURITIES PURCHASE AGREEMENT (the “Agreement”), dated as of April 11, 2023, by and between NovAccess Global Inc., a Colorado corporation, with its address at 8584 E. Washington Street #127, Chagrin Falls, Ohio 44023 (the “Company”), and 1800 DIAGONAL LENDING LLC, a Virginia limited liability company, with its address at 1800 Diagonal Road, Suite 623 |
|
| April 18, 2023 |
Exhibit 10.2 NEITHER THE ISSUANCE AND SALE OF THE SECURITIES REPRESENTED BY THIS CERTIFICATE NOR THE SECURITIES INTO WHICH THESE SECURITIES ARE CONVERTIBLE HAVE BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR APPLICABLE STATE SECURITIES LAWS. THE SECURITIES MAY NOT BE OFFERED FOR SALE, SOLD, TRANSFERRED OR ASSIGNED IN THE ABSENCE OF (A) AN EFFECTIVE REGISTRATION STATEMENT FOR THE |
|
| April 18, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 April 14, 2023 (Date of earliest event reported) NovAccess Global Inc. |
|
| March 16, 2023 |
Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 March 13, 2023 (Date of earliest event reported) NovAccess Global Inc. |
|
| February 23, 2023 |
XSNX / Novaccess Global Inc / AJB Capital Investments LLC - SCHEDULE 13G Passive Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. )* NOVACCESS GLOBAL, INC. (Name of Issuer) Common Stock, no par value (Title of Class of Securities) 67001N107 (CUSIP Number) February 15, 2023 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant t |
|
| February 14, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended December 31, 2022 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission file number: 000-29621 NovAccess Global Inc. (Exact name of registrant as |
|
| February 13, 2023 |
Exhibit 10.2 February 9, 2023 NOVACCESS GLOBAL INC. 8584 E. Washington Street, No. 127 Chagrin Falls, OH 44023 Attn: E-mail: VIA ELECTRONIC MAIL Re: Modifications Dear Sirs: Reference is made to that certain securities purchase agreements, dated February 15, 2022 and May 5, 2022, respectively, by and between NOVACCESS GLOBAL INC., a Colorado corporation (the “Company”), and AJB Capital Investments |
|
| February 13, 2023 |
Exhibit 10.1 Interest Free Loan Agreement This Interest Free Loan Agreement (this “Agreement”) is entered into as of February 9, 2023 (the “Effective Date”) by and between NovAccess Global Inc., a Colorado corporation (“NovAccess”), and Jason M. Anderson (“Anderson”). Whereas, NovAccess is currently seeking financing to fund its operations, but requires a short-term loan to fund operations until l |
|
| February 13, 2023 |
Exhibit 10.3 NEITHER THIS SECURITY NOR THE SECURITIES AS TO WHICH THIS SECURITY MAY BE EXERCISED HAVE BEEN REGISTERED WITH THE SECURITIES AND EXCHANGE COMMISSION OR THE SECURITIES COMMISSION OF ANY STATE IN RELIANCE UPON AN EXEMPTION FROM REGISTRATION UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”), AND, ACCORDINGLY, MAY NOT BE OFFERED OR SOLD EXCEPT PURSUANT TO AN EFFECTIVE RE |
|
| February 13, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 February 9, 2023 (Date of earliest event reported) NovAccess Global Inc. |
|
| January 23, 2023 |
Exhibit 10.1 January 20, 2023 NOVACCESS GLOBAL INC. 8584 E. Washington Street, #127 Chagrin Falls, OH 44023 Attn: CEO E-mail: [email protected] VIA ELECTRONIC MAIL Re: Modifications Dear Neil: Reference is made to those three securities purchase agreements dated August 20, 2021, February 15, 2022, and May 5, 2022 by and between NovAccess Global Inc., a Colorado corporation (the “Company”), |
|
| January 23, 2023 |
Entry into a Material Definitive Agreement, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 January 20, 2023 (Date of earliest event reported) NovAccess Global Inc. |
|
| January 10, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended September 30, 2022 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission file number: 000-29621 NovAccess Global Inc. (Exact name of registrant as specifi |
|
| December 29, 2022 |
NT 10-K 1 novaccess20221229nt10k.htm FORM NT 10-K SEC FILE NUMBER 000-29621 CUSIP NUMBER 67001N 107 UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 12b-25 NOTIFICATION OF LATE FILING (Check One): ☒ Form 10-K ☐ Form 20-F ☐ Form 11-K ☐ Form 10-Q ☐ Form 10-D ☐ Form N-CEN ☐ Form N-CSR For Period Ended: September 30, 2022 ☐ Transition Report on Form 10-K ☐ Transition Report |
|
| December 13, 2022 |
Exhibit 10.1 SECURITIES PURCHASE AGREEMENT This SECURITIES PURCHASE AGREEMENT (the ?Agreement?), dated as of December 7, 2022, by and between NovAccess Global Inc., a Colorado corporation, with its address at 8584 E. Washington Street #127, Chagrin Falls, Ohio 44023 (the ?Company?), and 1800 DIAGONAL LENDING LLC, a Virginia limited liability company, with its address at 1800 Diagonal Road, Suite 6 |
|
| December 13, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 December 13, 2022 (Date of earliest event reported) NovAccess Global Inc. |
|
| December 13, 2022 |
Exhibit 10.2 NEITHER THE ISSUANCE AND SALE OF THE SECURITIES REPRESENTED BY THIS CERTIFICATE NOR THE SECURITIES INTO WHICH THESE SECURITIES ARE CONVERTIBLE HAVE BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR APPLICABLE STATE SECURITIES LAWS. THE SECURITIES MAY NOT BE OFFERED FOR SALE, SOLD, TRANSFERRED OR ASSIGNED IN THE ABSENCE OF (A) AN EFFECTIVE REGISTRATION STATEMENT FOR THE |
|
| November 23, 2022 |
Exhibit 99.1 |
|
| November 23, 2022 |
Financial Statements and Exhibits, Submission of Matters to a Vote of Security Holders UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 November 21, 2022 (Date of earliest event reported) NovAccess Global Inc. |
|
| November 9, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 November 7, 2022 (Date of earliest event reported) NovAccess Global Inc. |
|
| November 9, 2022 |
Exhibit 20.1 Notice of Annual Meeting of Shareholders To Be Held November 21, 2022 NovAccess Global Inc., a Colorado corporation, will hold its 2022 annual meeting of shareholders on Monday, November 21, 2022, starting at 11:00 AM EST/8:00 AM PST. Only shareholders of record at the close of business on November 11, 2022 are entitled to vote at the meeting and at any adjournment or postponement of |
|
| November 9, 2022 |
Exhibit 10.2 NEITHER THE ISSUANCE AND SALE OF THE SECURITIES REPRESENTED BY THIS CERTIFICATE NOR THE SECURITIES INTO WHICH THESE SECURITIES ARE CONVERTIBLE HAVE BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR APPLICABLE STATE SECURITIES LAWS. THE SECURITIES MAY NOT BE OFFERED FOR SALE, SOLD, TRANSFERRED OR ASSIGNED IN THE ABSENCE OF (A) AN EFFECTIVE REGISTRATION STATEMENT FOR THE |
|
| November 9, 2022 |
Exhibit 10.1 SECURITIES PURCHASE AGREEMENT This SECURITIES PURCHASE AGREEMENT (the ?Agreement?), dated as of November 1, 2022, by and between NovAccess Global Inc., a Colorado corporation, with its address at 8584 E. Washington Street #127, Chagrin Falls, Ohio 44023 (the ?Company?), and 1800 DIAGONAL LENDING LLC, a Virginia limited liability company, with its address at 1800 Diagonal Road, Suite 6 |
|
| November 9, 2022 |
Exhibit 20.2 Press Release of NovAccess Global Inc. dated November 8, 2022 Exhibit 20.2 NovAccess Global Announces Virtual Annual Shareholders? Meeting Invites all Shareholders and Investors to Participate Cleveland, OH ? November 8, 2022 ? NovAccess Global Inc. (OTCQB: XSNX), a biomedical company developing novel immunotherapies for brain tumor patients, today announced that its annual meeting of shareholders will take place on November 21, 2022, at 11:00 am Eastern tim |
|
| October 28, 2022 |
Financial Statements and Exhibits, Other Events UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 October 25, 2022 (Date of earliest event reported) NovAccess Global Inc. |
|
| October 28, 2022 |
Exhibit 20.1 NovAccess Global Receives FDA Approval of Orphan Drug Application for TLR-AD1 FDA Expands the Scope of the Company’s Submission Accelerates Path Toward Immunotherapy for Glioblastoma (Brain Cancer) Cleveland, OH – October 26, 2022 - NovAccess Global Inc. (OTCQB: XSNX), a biomedical company developing novel immunotherapies for brain tumor patients, today announced the approval of its a |
|
| September 29, 2022 |
Exhibit 10.2 NEITHER THE ISSUANCE AND SALE OF THE SECURITIES REPRESENTED BY THIS CERTIFICATE NOR THE SECURITIES INTO WHICH THESE SECURITIES ARE CONVERTIBLE HAVE BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR APPLICABLE STATE SECURITIES LAWS. THE SECURITIES MAY NOT BE OFFERED FOR SALE, SOLD, TRANSFERRED OR ASSIGNED IN THE ABSENCE OF (A) AN EFFECTIVE REGISTRATION STATEMENT FOR THE |
|
| September 29, 2022 |
Exhibit 10.1 SECURITIES PURCHASE AGREEMENT This SECURITIES PURCHASE AGREEMENT (the ?Agreement?), dated as of September 22, 2022, by and between NovAccess Global Inc., a Colorado corporation, with its address at 8584 E. Washington Street #127, Chagrin Falls, Ohio 44023 (the ?Company?), and 1800 DIAGONAL LENDING LLC, a Virginia limited liability company, with its address at 1800 Diagonal Road, Suite |
|
| September 29, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 September 28, 2022 (Date of earliest event reported) NovAccess Global Inc. |
|
| September 19, 2022 |
Up to 23,889,211 Shares of Common Stock Filed Pursuant to Rule 424(b)(3) Registration No. 333-265800 PROSPECTUS Up to 23,889,211 Shares of Common Stock This prospectus relates to the offer and sale of up to 23,889,211 shares of common stock, no par value, of NovAccess Global Inc., a Colorado corporation, by the selling shareholders. We are not selling any securities under this prospectus and will not receive any of the proceeds from the |
|
| September 14, 2022 |
September 14, 2022 VIA EDGAR Securities and Exchange Commission Division of Corporation Finance Office of Manufacturing Attn: Evan Ewing Re: NovAccess Global Inc. |
|
| September 2, 2022 |
As filed with the Securities and Exchange Commission on September 2 , 2022 As filed with the Securities and Exchange Commission on September 2 , 2022 Registration No. |
|
| September 2, 2022 |
Exhibit 107 Calculation of Filing Fee Tables Form S-1 (Form Type) NovAccess Global Inc. |
|
| September 2, 2022 |
CHRISTOPHER J. HUBBERT | Partner CORRESP 1 filename1.htm CHRISTOPHER J. HUBBERT | Partner Direct: 216.736.7215 | [email protected] VIA EMAIL & EDGAR September 2, 2022 Securities and Exchange Commission Division of Corporation Finance Office of Manufacturing Attn: Evan Ewing Re: NovAccess Global Inc. Registration Statement on Form S-1 Filed June 23, 2022 File No. 333-265800 Dear Mr. Ewing: Please accept this correspondence as NovAccess |
|
| August 15, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2022 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 000-29621 NovAccess |
|
| August 9, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 August 8, 2022 (Date of earliest event reported) NovAccess Global Inc. |
|
| August 9, 2022 |
Exhibit 10.1 THIS NOTE HAS NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE ?SECURITIES ACT?), OR UNDER THE SECURITIES LAWS OF ANY STATE. THIS NOTE MAY NOT BE OFFERED, SOLD OR OTHERWISE TRANSFERRED, PLEDGED OR HYPOTHECATED EXCEPT AS PERMITTED UNDER THE SECURITIES ACT AND APPLICABLE STATE SECURITIES LAWS PURSUANT TO AN EFFECTIVE REGISTRATION STATEMENT OR AN EXEMPTION THEREFROM. |
|
| August 2, 2022 |
Exhibit 10.1 Interest Free Loan Agreement This Interest Free Loan Agreement (this ?Agreement?) is entered into as of July 28, 2022 (the ?Effective Date?) by and between NovAccess Global Inc., a Colorado corporation (?NovAccess?), and Jason M. Anderson (?Anderson?). Whereas, NovAccess is currently seeking financing to fund its operations, but requires a short-term loan to fund operations until long |
|
| August 2, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 July 28, 2022 (Date of earliest event reported) NovAccess Global Inc. |
|
| August 2, 2022 |
Exhibit 10.2 THIS NOTE HAS NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE ?SECURITIES ACT?), OR UNDER THE SECURITIES LAWS OF ANY STATE. THIS NOTE MAY NOT BE OFFERED, SOLD OR OTHERWISE TRANSFERRED, PLEDGED OR HYPOTHECATED EXCEPT AS PERMITTED UNDER THE SECURITIES ACT AND APPLICABLE STATE SECURITIES LAWS PURSUANT TO AN EFFECTIVE REGISTRATION STATEMENT OR AN EXEMPTION THEREFROM. |
|
| July 8, 2022 |
United States securities and exchange commission logo July 8, 2022 Neil Laird Chief Financial Officer NovAccess Global Inc. |
|
| June 23, 2022 |
Exhibit 107 Calculation of Filing Fee Tables Form S-1 (Form Type) NovAccess Global Inc. |
|
| June 23, 2022 |
Exhibit 21.1 Subsidiaries of NovAccess Global Inc. StemVax, LLC, a California limited liability company |
|
| June 23, 2022 |
As filed with the Securities and Exchange Commission on June 23, 2022 As filed with the Securities and Exchange Commission on June 23, 2022 Registration No. |
|
| May 17, 2022 |
XSNX / XsunX, Inc. / AJB Capital Investments LLC - SCHEDULE 13G Passive Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. )* NOVACCESS GLOBAL, INC. (Name of Issuer) Common Stock, no par value (Title of Class of Securities) 67001N 107 (CUSIP Number) May 16, 2022 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to wh |
|
| May 16, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ? QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2022 or ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 000-29621 NovAccess |
|
| May 16, 2022 |
Entry into a Material Definitive Agreement, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 May 12, 2022 (Date of earliest event reported) NovAccess Global Inc. |
|
| May 16, 2022 |
Exhibit 10.1 NovAccess Global Inc. 2022 Equity Incentive Plan Exhibit 10.1 NovAccess Global Inc. 2022 Equity Incentive Plan 1. Purpose; Eligibility. 1.1 General Purpose. The name of this plan is the NovAccess Global Inc. 2022 Equity Incentive Plan (the ?Plan?). The purposes of the Plan are to (a) enable NovAccess Global Inc., a Colorado corporation (the ?Company?), and any Affiliate to attract and retain the types of Employees, Consultants and Directors who |
|
| May 10, 2022 |
Exhibit 10.3 NEITHER THIS SECURITY NOR THE SECURITIES AS TO WHICH THIS SECURITY MAY BE EXERCISED HAVE BEEN REGISTERED WITH THE SECURITIES AND EXCHANGE COMMISSION OR THE SECURITIES COMMISSION OF ANY STATE IN RELIANCE UPON AN EXEMPTION FROM REGISTRATION UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE ?SECURITIES ACT?), AND, ACCORDINGLY, MAY NOT BE OFFERED OR SOLD EXCEPT PURSUANT TO AN EFFECTIVE RE |
|
| May 10, 2022 |
Exhibit 10.5 REGISTRATION RIGHTS AGREEMENT This REGISTRATION RIGHTS AGREEMENT (the ?Agreement?), dated as of May 5, 2022, by and between NOVACCESS GLOBAL INC., a Colorado corporation, with an address of 8584 E. Washington Street, No. 127, Chagrin Falls, Ohio 44023 (the ?Company?), and AJB CAPITAL INVESTMENTS, LLC, a Delaware limited liability company, with offices at 4700 Sheridan Street, Suite J, |
|
| May 10, 2022 |
Exhibit 10.2 NEITHER THE ISSUANCE AND SALE OF THE SECURITIES REPRESENTED BY THIS CERTIFICATE NOR THE SECURITIES INTO WHICH THESE SECURITIES ARE CONVERTIBLE HAVE BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR APPLICABLE STATE SECURITIES LAWS. THE SECURITIES MAY NOT BE OFFERED FOR SALE, SOLD, TRANSFERRED OR ASSIGNED (I) IN THE ABSENCE OF (A) AN EFFECTIVE REGISTRATION STATEMENT FOR |
|
| May 10, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 May 5, 2022 (Date of earliest event reported) NovAccess Global Inc. |
|
| May 10, 2022 |
Exhibit 10.1 SECURITIES PURCHASE AGREEMENT This SECURITIES PURCHASE AGREEMENT (the ?Agreement?), dated as of May 5, 2022, by and between NOVACCESS GLOBAL INC., a Colorado corporation, with headquarters located at 8584 E. Washington Street, #127, Chagrin Falls, OH 44023 (the ?Company?), and AJB CAPITAL INVESTMENTS, LLC, a Delaware limited liability company, with its address at 4700 Sheridan Street, |
|
| May 10, 2022 |
Exhibit 10.4 SECURITY AGREEMENT This SECURITY AGREEMENT (this ?Agreement?) made and effective as of May 5, 2022, is executed by and between NOVACCESS GLOBAL INC., a Colorado corporation (the ?Company?), and AJB CAPITAL INVESTMENTS, LLC, a Delaware limited liability company (the ?Secured Party?). WHEREAS, pursuant to a Securities Purchase Agreement dated as of the date hereof, between the Company a |
|
| March 24, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 March 18, 2022 (Date of earliest event reported) NovAccess Global Inc. |
|
| March 14, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 March 14, 2022 (Date of earliest event reported) NovAccess Global Inc. |
|
| March 14, 2022 |
XSNX / XsunX, Inc. / Morris-Irvin Dwain - SCHEDULE 13D/A Activist Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington D.C. 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 (Amendment No. 1) NovAccess Global Inc. (Name of Issuer) Common Stock, no par value per share (Title of Class of Securities) 98385L 10 2 (CUSIP Number) Christopher J. Hubbert 1375 East Ninth Street, 29th Floor Cleveland, Ohio 44114 216-736-7215 (Name, Address and Telephone |
|
| March 14, 2022 |
XSNX / XsunX, Inc. / Martin Daniel G. - SCHEDULE 13D/A Activist Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington D.C. 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 (Amendment No. 1) NovAccess Global Inc. (Name of Issuer) Common Stock, no par value per share (Title of Class of Securities) 98385L 10 2 (CUSIP Number) Christopher J. Hubbert 1375 East Ninth Street, 29th Floor Cleveland, Ohio 44114 216-736-7215 (Name, Address and Telephone |
|
| March 14, 2022 |
Exhibit 10.2 Common Stock Distribution Agreement This Common Stock Distribution Agreement (this ?Agreement?) is entered into effective March 14, 2022 by NovAccess Global Inc., a Colorado corporation (?NovAccess?), and Innovest Global, Inc., a Nevada corporation (?Innovest?). Recitals A. Innovest owns 7,500,000 shares of NovAccess common stock, no par value (the ?Shares?), that NovAccess issued to |
|
| March 1, 2022 |
United States securities and exchange commission logo March 1, 2022 Neil J. Laird Chief Financial Officer NovAccess Global Inc. 8834 Mayfield Road, Suite C Chesterland , Ohio 44026 Re: NovAccess Global Inc. Form 10-K for the year ended September 30, 2021 Filed January 13, 2022 File No. 000-29621 Dear Mr. Laird: We have completed our review of your filing. We remind you that the company and its man |
|
| February 28, 2022 |
CORRESP 1 filename1.htm February 28, 2022 Via EDGAR United States Securities and Exchange Commission Division of Corporation Finance Office of Manufacturing Washington, D.C. 20549 Attention: Ernest Greene Re: NovAccess Global Inc. Form 10-K for the year ended September 30, 2021 Filed January 13, 2022 File No. 000-29621 Dear Mr. Greene: Please find below the response of NovAccess Global Inc. (“we,” |
|
| February 25, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 14F-1 INFORMATION STATEMENT PURSUANT TO SECTION 14(f) OF THE SECURITIES EXCHANGE ACT OF 1934 AND RULE 14f-1 THEREUNDER NovAccess Global Inc. (Exact name of registrant as specified in its corporate charter) Commission File No.: 000-29621 Colorado 84-1384159 (State of incorporation) (I.R.S. Employer Identification No.) |
|
| February 18, 2022 |
Exhibit 10.2 NEITHER THE ISSUANCE AND SALE OF THE SECURITIES REPRESENTED BY THIS CERTIFICATE NOR THE SECURITIES INTO WHICH THESE SECURITIES ARE CONVERTIBLE HAVE BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR APPLICABLE STATE SECURITIES LAWS. THE SECURITIES MAY NOT BE OFFERED FOR SALE, SOLD, TRANSFERRED OR ASSIGNED (I) IN THE ABSENCE OF (A) AN EFFECTIVE REGISTRATION STATEMENT FOR |
|
| February 18, 2022 |
Exhibit 10.4 SECURITY AGREEMENT This SECURITY AGREEMENT (this ?Agreement?) made and effective as of February 15, 2022, is executed by and between NOVACCESS GLOBAL INC., a Colorado corporation (the ?Company?), and AJB CAPITAL INVESTMENTS, LLC, a Delaware limited liability company (the ?Secured Party?). WHEREAS, pursuant to a Securities Purchase Agreement dated as of the date hereof, between the Com |
|
| February 18, 2022 |
Exhibit 10.1 SECURITIES PURCHASE AGREEMENT This SECURITIES PURCHASE AGREEMENT (the ?Agreement?), dated as of February 15, 2022, by and between NOVACCESS GLOBAL INC., a Colorado corporation, with headquarters located at 8834 Mayfield Road, Suite C, Chesterland, OH 44026 (the ?Company?), and AJB CAPITAL INVESTMENTS, LLC, a Delaware limited liability company, with its address at 4700 Sheridan Street, |
|
| February 18, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 February 15, 2022 (Date of earliest event reported) NovAccess Global Inc. |
|
| February 18, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended December 31, 2021 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 000-29621 NovAcc |
|
| February 18, 2022 |
Exhibit 10.3 NEITHER THIS SECURITY NOR THE SECURITIES AS TO WHICH THIS SECURITY MAY BE EXERCISED HAVE BEEN REGISTERED WITH THE SECURITIES AND EXCHANGE COMMISSION OR THE SECURITIES COMMISSION OF ANY STATE IN RELIANCE UPON AN EXEMPTION FROM REGISTRATION UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE ?SECURITIES ACT?), AND, ACCORDINGLY, MAY NOT BE OFFERED OR SOLD EXCEPT PURSUANT TO AN EFFECTIVE RE |
|
| February 15, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 NT 10-Q 1 novaccess20220214nt10q.htm FORM NT 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SEC FILE NUMBER 000-29621 CUSIP NUMBER 98385L 10 2 FORM 12b-25 NOTIFICATION OF LATE FILING (Check One): ☐ Form 10-K ☐ Form 20- F ☐ Form 11-K ☒ Form 10-Q ☐ Form 10-D ☐ Form N-CEN ☐ Form N-CSR For Period Ended: December 31, 2021 ☐ Transition Report on Form 10-K ☐ Transition Repor |
|
| February 14, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 14F-1 INFORMATION STATEMENT PURSUANT TO SECTION 14(f) OF THE SECURITIES EXCHANGE ACT OF 1934 AND RULE 14f-1 THEREUNDER NovAccess Global Inc. (Exact name of registrant as specified in its corporate charter) Commission File No.: 000-29621 Colorado 84-1384159 (State of incorporation) (I.R.S. Employer Identification No.) |
|
| February 3, 2022 |
United States securities and exchange commission logo February 3, 2022 Neil J. Laird Chief Financial Officer NovAccess Global Inc. 8834 Mayfield Road, Suite C Chesterland , Ohio 44026 Re: NovAccess Global Inc. Form 10-K for the year ended September 30, 2021 Filed January 13, 2022 File No. 000-29621 Dear Mr. Laird: We have limited our review of your filing to the financial statements and related di |
|
| February 2, 2022 |
Entry into a Material Definitive Agreement, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 January 31, 2022 (Date of earliest event reported) NovAccess Global Inc. |
|
| February 2, 2022 |
Exhibit 10.1 Preferred Stock Purchase and Redemption Agreement This Preferred Stock Purchase and Redemption Agreement (this ?Agreement?) is entered into effective January 31, 2022 (the ?Effective Date?) by NovAccess Global Inc., a Colorado corporation (?NovAccess?), TN3, LLC, a Wyoming limited liability company (?TN3?), Mr. Daniel G. Martin, individually (?Martin?), Irvin Consulting, LLC, a Califo |
|
| January 18, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 January 17, 2022 (Date of earliest event reported) NovAccess Global Inc. |
|
| January 13, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K ? ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended September 30, 2021 OR ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission file number: 000-29621 NovAccess Global Inc. (Exact name of registrant as specifi |
|
| January 3, 2022 |
Exhibit 10.1 THIS NOTE HAS NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE ?SECURITIES ACT?), OR UNDER THE SECURITIES LAWS OF ANY STATE. THIS NOTE MAY NOT BE OFFERED, SOLD OR OTHERWISE TRANSFERRED, PLEDGED OR HYPOTHECATED EXCEPT AS PERMITTED UNDER THE SECURITIES ACT AND APPLICABLE STATE SECURITIES LAWS PURSUANT TO AN EFFECTIVE REGISTRATION STATEMENT OR AN EXEMPTION THEREFROM. |
|
| January 3, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 December 30, 2021 (Date of earliest event reported) NovAccess Global Inc. |
|
| December 30, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SEC FILE NUMBER 000-29621 CUSIP NUMBER 98385L 10 2 FORM 12b-25 NOTIFICATION OF LATE FILING (Check One): ☒ Form 10-K ☐ Form 20- F ☐ Form 11-K ☐ Form 10-Q ☐ Form 10-D ☐ Form N-CEN ☐ Form N-CSR For Period Ended: September 30, 2021 ☐ Transition Report on Form 10-K ☐ Transition Report on Form 20-F ☐ Transition Report on Form 11-K ☐ |
|
| November 24, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 14F-1/A INFORMATION STATEMENT PURSUANT TO SECTION 14(f) OF THE SECURITIES EXCHANGE ACT OF 1934 AND RULE 14f-1 THEREUNDER NovAccess Global Inc. (Exact name of registrant as specified in its corporate charter) Commission File No.: 000-29621 Colorado 84-1384159 (State or other jurisdiction of incorporation or organizatio |
|
| November 10, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 14F-1 INFORMATION STATEMENT PURSUANT TO SECTION 14(f) OF THE SECURITIES EXCHANGE ACT OF 1934 AND RULE 14f-1 THEREUNDER NovAccess Global Inc. (Exact name of registrant as specified in its corporate charter) Commission File No.: 000-29621 Colorado 84-1384159 (State or other jurisdiction of incorporation or organization) |
|
| September 13, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 September 10, 2021 (Date of earliest event reported) NovAccess Global Inc. |
|
| August 25, 2021 |
Exhibit 10.1 SECURITIES PURCHASE AGREEMENT This SECURITIES PURCHASE AGREEMENT (the ?Agreement?), dated as of August 20, 2021, by and between NOVACCESS GLOBAL INC., a Colorado corporation, with headquarters located at 8834 Mayfield Road, Suite C, Chesterland, OH 44026 (the ?Company?), and AJB CAPITAL INVESTMENTS, LLC, a Delaware limited liability company, with its address at 4700 Sheridan Street, S |
|
| August 25, 2021 |
Exhibit 10.4 SECURITY AGREEMENT This SECURITY AGREEMENT (this ?Agreement?) made and effective as of August 20, 2021, is executed by and between NOVACCESS GLOBAL INC., a Colorado corporation (the ?Company?), and AJB CAPITAL INVESTMENTS, LLC, a Delaware limited liability company (the ?Secured Party?). WHEREAS, pursuant to a Securities Purchase Agreement dated as of the date hereof, between the Compa |
|
| August 25, 2021 |
Exhibit 10.3 NEITHER THIS SECURITY NOR THE SECURITIES AS TO WHICH THIS SECURITY MAY BE EXERCISED HAVE BEEN REGISTERED WITH THE SECURITIES AND EXCHANGE COMMISSION OR THE SECURITIES COMMISSION OF ANY STATE IN RELIANCE UPON AN EXEMPTION FROM REGISTRATION UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE ?SECURITIES ACT?), AND, ACCORDINGLY, MAY NOT BE OFFERED OR SOLD EXCEPT PURSUANT TO AN EFFECTIVE RE |
|
| August 25, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 August 20, 2021 (Date of earliest event reported) NovAccess Global Inc. |
|
| August 25, 2021 |
Exhibit 10.2 NEITHER THE ISSUANCE AND SALE OF THE SECURITIES REPRESENTED BY THIS CERTIFICATE NOR THE SECURITIES INTO WHICH THESE SECURITIES ARE CONVERTIBLE HAVE BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR APPLICABLE STATE SECURITIES LAWS. THE SECURITIES MAY NOT BE OFFERED FOR SALE, SOLD, TRANSFERRED OR ASSIGNED (I) IN THE ABSENCE OF (A) AN EFFECTIVE REGISTRATION STATEMENT FOR |
|
| August 13, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ? QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2021 or ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 000-29621 NovAccess |
|
| July 16, 2021 |
Exhibit 10.1 SECURITIES PURCHASE AGREEMENT This SECURITIES PURCHASE AGREEMENT (the ?Agreement?), dated as of July 6, 2021, by and between NovAccess Global Inc., a Colorado corporation, with its address at 8834 Mayfield Road, Suite C, Chesterland, Ohio 44026 (the ?Company?), and POWER UP LENDING GROUP LTD., a Virginia corporation, with its address at 111 Great Neck Road, Suite 216, Great Neck, NY 1 |
|
| July 16, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 July 12, 2021 (Date of earliest event reported) NovAccess Global Inc. |
|
| July 16, 2021 |
Exhibit 10.2 NEITHER THE ISSUANCE AND SALE OF THE SECURITIES REPRESENTED BY THIS CERTIFICATE NOR THE SECURITIES INTO WHICH THESE SECURITIES ARE CONVERTIBLE HAVE BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR APPLICABLE STATE SECURITIES LAWS. THE SECURITIES MAY NOT BE OFFERED FOR SALE, SOLD, TRANSFERRED OR ASSIGNED IN THE ABSENCE OF (A) AN EFFECTIVE REGISTRATION STATEMENT FOR THE |
|
| June 21, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 May 28, 2021 (Date of earliest event reported) NovAccess Global Inc. |
|
| June 21, 2021 |
Exhibit 10.2 NEITHER THE ISSUANCE AND SALE OF THE SECURITIES REPRESENTED BY THIS CERTIFICATE NOR THE SECURITIES INTO WHICH THESE SECURITIES ARE CONVERTIBLE HAVE BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR APPLICABLE STATE SECURITIES LAWS. THE SECURITIES MAY NOT BE OFFERED FOR SALE, SOLD, TRANSFERRED OR ASSIGNED IN THE ABSENCE OF (A) AN EFFECTIVE REGISTRATION STATEMENT FOR THE |
|
| June 21, 2021 |
Exhibit 10.1 SECURITIES PURCHASE AGREEMENT This SECURITIES PURCHASE AGREEMENT (the ?Agreement?), dated as of May 28, 2021, by and between NovAccess Global Inc., a Colorado corporation, with its address at 8834 Mayfield Road, Suite C, Chesterland, Ohio 44026 (the ?Company?), and POWER UP LENDING GROUP LTD., a Virginia corporation, with its address at 111 Great Neck Road, Suite 216, Great Neck, NY 1 |
|
| May 20, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ? QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2021 or ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 000-29621 NovAccess |
|
| May 20, 2021 |
Exhibit 10.1 LOAN AGREEMENT $25,000 Dated: March 30, 2021 FOR VALUE RECEIVED, NovAccess Global,(?NOVACESS?) hereby promises to pay to Innovest Global Inc. (the ?Holder?), or its assigns, the principal amount of Twenty Five Thousand dollars ($25,000) with waived interest accrued on the unpaid principal balance, all of such principal. Payments of principal and interest hereon shall be made in lawful |
|
| May 18, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SEC FILE NUMBER 000-29621 CUSIP NUMBER 98385L 10 2 FORM 12b-25 NOTIFICATION OF LATE FILING (Check One): ? Form 10-K ? Form 20-F ? Form 11-K ? Form 10-Q ? Form 10-D ? Form N-CEN ? Form N-CSR For Period Ended: March 31, 2021 ? Transition Report on Form 10-K ? Transition Report on Form 20-F ? Transition Report on Form 11-K ? Tran |
|
| May 6, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ? QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended December 31, 2020 or ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 000-29621 NovAcc |
|
| April 16, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington D.C. 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 (Amendment No. ) NovAccess Global Inc. (Name of Issuer) Common Stock, no par value per share (Title of Class of Securities) 98385L 10 2 (CUSIP Number) Christopher J. Hubbert 1375 East Ninth Street, 29th Floor Cleveland, Ohio 44114 216-736-7215 (Name, Address and Telephone N |
|
| March 30, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K ? ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended September 30, 2020 OR ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission file number: 000-29621 NovAccess Global Inc. (Exact name of registrant as specifi |
|
| March 30, 2021 |
Exhibit 10.4 THIS WARRANT AND THE SECURITIES ISSUABLE UPON EXERCISE HEREOF HAVE BEEN ACQUIRED FOR INVESTMENT AND HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE ?ACT?), OR ANY STATE SECURITIES LAW. THIS WARRANT AND SUCH SECURITIES MAY NOT BE OFFERED, SOLD OR OTHERWISE PLEDGED, TRANSFERRED OR HYPOTHECATED IN THE ABSENCE OF SUCH REGISTRATION OR DELIVERY OF AN OPINION OF CO |
|
| March 30, 2021 |
Transition Services Agreement dated June 2, 2020 between the Company and Solar Energy Builders, Inc. Exhibit 10.5 TRANSITION SERVICES AGREEMENT THIS TRANSITION SERVICES AGREEMENT (?Agreement?) is made and entered into as of June 2, 2020 (the ?Effective Date?), by and between XsunX, Inc., a Colorado corporation (the ?Company?), and Solar Energy Builders, Inc., a California corporation (the ?Service Provider?), with respect to the following facts: RECITALS A. The Company is currently engaged in the |
|
| March 30, 2021 |
Exhibit 10.3 Membership Interest Purchase Agreement This Membership Interest Purchase Agreement (this ?Agreement?) is entered into effective June 1, 2020 by XsunX, Inc., a Colorado corporation (?Buyer?), and Innovest Global, Inc., a Nevada corporation (?Seller?). Recitals A. Seller is the sole owner of StemVax, LLC, a California limited liability company (?StemVax?). B. Buyer desires to purchase S |
|
| December 30, 2020 |
SEC FILE NUMBER 000-29621 CUSIP NUMBER 98385L 10 2 UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D. |
|
| October 27, 2020 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): October 21, 2020 NovAccess Global Inc. (Exact name of registrant as specified in its charter) Colorado 000-29621 84-1384159 (State or other jurisdiction of incorporation) (Commission |
|
| October 21, 2020 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): October 15, 2020 NovAccess Global Inc. (Exact name of registrant as specified in its charter) Colorado 000-29621 84-1384159 (State or other jurisdiction of incorporation) (Commission |
|
| September 16, 2020 |
XSNX / XsunX, Inc. / Innovest Global, Inc. - SCHEDULE 13D Activist Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington D.C. 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 (Amendment No. ) NovAccess Global Inc. (Name of Issuer) Common Stock, no par value per share (Title of Class of Securities) 98385L 10 2 (CUSIP Number) Christopher J. Hubbert 1375 East Ninth Street, 29th Floor Cleveland, Ohio 44114 216-736-7215 (Name, Address and Telephone N |
|
| September 11, 2020 |
Management Services Agreement between NovAccess Global Inc. and TN3, LLC dated September 4, 2020 Exhibit 10.1 MANAGEMENT SERVICES AGREEMENT This MANAGEMENT SERVICES AGREEMENT (this “Agreement”) is made and entered into as of September 4, 2020 for services begun June 2, 2020 (the “Effective Date”), by and between TN3 LLC, a Wyoming limited liability company (the “Service Provider”), and NovAccess Global Inc., a Colorado corporation (together with its subsidiaries, the “Company”). Service Provi |
|
| September 11, 2020 |
Certificate of Designation of Series B Convertible Preferred Stock dated September 4, 2020 Exhibit 3.1 Certificate of Designation of Series B Convertible Preferred Stock of NovAccess Global Inc. Pursuant to Section 7-106-102 of the Colorado Revised Statutes, NovAccess Global Inc., a Colorado corporation organized (the “Corporation”), does hereby submit the following: Whereas, the Articles of Incorporation of the Corporation (the “Articles of Incorporation”) authorizes the issuance of up |
|
| September 11, 2020 |
Exhibit 99.1 NovAccess Global Acquires StemVax Therapeutics from Innovest Global Acquisition Launches NovAccess Shift, Focusing on Diagnostics and Therapeutics in Cancer CLEVELAND, OH – September 9, 2020 – NovAccess Global, Inc. (OTC: XSNX), today announced that it has acquired 100% ownership of Pasadena-based StemVax Therapeutics from Innovest Global (OTC: IVST). StemVax is a translational biotec |
|
| September 11, 2020 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): September 4, 2020 NovAccess Global Inc. (Exact name of registrant as specified in its charter) Colorado 000-29621 84-1384159 (State or other jurisdiction of incorporation) (Commission |
|
| August 27, 2020 |
Articles of Amendment to Articles of Incorporation dated August 25, 2020 Exhibit 3.1 ARTICLES OF AMENDMENT OF ARTICLES OF INCORPORATION OF XSUNX, INC. The undersigned Chief Executive Officer of XSUNX, INC., a Colorado corporation (the “Corporation”), does hereby certify that the holder of the shares of the Corporation entitled to cast a majority of the votes on this matter executed an action by written consent dated June 15, 2020, adopting resolutions to amend the Arti |
|
| August 27, 2020 |
Exhibit 99.1 XsunX, Inc. Changes Name to NovAccess Global Inc. Name Change, Reverse Stock Split, and Other Planned Corporate Actions Highlight Focus on Enhancing Shareholder Value CLEVELAND, OH - August 26, 2020 — NovAccess Global Inc. (OTC PINK: XSNX), today effectuated a 1-for-1,000 reverse stock split in conjunction with its new name, in order to prepare for the business model being implemented |
|
| August 27, 2020 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 25, 2020 NovAccess Global Inc. (Exact name of registrant as specified in its charter) Colorado 000-29621 84-1384159 (State or other jurisdiction of incorporation) (Commission F |
|
| August 21, 2020 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ Quarterly Report Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 For The Quarterly Period Ended: June 30, 2020 ☐ Transition Report Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 For The Transition Period From to Commission File Number: 000-29621 XSUNX, INC. (Exact name |
|
| August 17, 2020 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 NOTIFICATION OF LATE FILING SEC FILE NUMBER 000-29621 CUSIP NUMBER 98385L 10 2 (Check one): ☐ Form 10-K ☐ Form 20-F ☐ Form 11-K ☒ Form 10-Q ☐ Form 10-D ☐ Form N-CEN ☐ Form N-CSR For Period Ended: June 30, 2020 ☐ Transition Report on Form 10-K ☐ Transition Report on Form 20-F ☐ Transition Report on Form 11-K ☐ Trans |
|
| June 30, 2020 |
Form 14C shareholder information statement related to biotechnology (3) UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 INFORMATION STATEMENT SCHEDULE 14C INFORMATION (Rule 14c-101) Information Statement Pursuant to Section 14(c) of the Securities Exchange Act of 1934 Check the appropriate box: ☐ Preliminary Information Statement ☐ Confidential, For Us of the Commission Only (as permitted by Rule 14c-5(d)(2)) ☒ Definitive Information Statement |
|
| June 12, 2020 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 INFORMATION STATEMENT SCHEDULE 14C INFORMATION (Rule 14c-101) Information Statement Pursuant to Section 14(c) of the Securities Exchange Act of 1934 Check the appropriate box: ☒ Preliminary Information Statement ☐ Confidential, For Us of the Commission Only (as permitted by Rule 14c-5(d)(2)) ☐ Definitive Information Statement |
|
| June 10, 2020 |
XSNX / XsunX, Inc. / Martin Daniel G. - SCHEDULE 13D Activist Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington D.C. 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 (Amendment No. ) XsunX, Inc. (Name of Issuer) Common Stock, no par value per share (Title of Class of Securities) 98385L 10 2 (CUSIP Number) Christopher J. Hubbert 1375 East Ninth Street, 29th Floor Cleveland, Ohio 44114 216-736-7215 (Name, Address and Telephone Number of P |
|
| June 8, 2020 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): June 2, 2020 XsunX, Inc. (Exact name of registrant as specified in its charter) Colorado 000-29621 84-1384159 (State or other jurisdiction of incorporation) (Commission File Number) ( |
|
| May 15, 2020 |
XSNX / XsunX, Inc. / DJOKOVICH THOMAS - SCHEDULE 13D Activist Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON DC 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 XsunX, Inc. |
|
| May 14, 2020 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ Quarterly Report Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 For The Quarterly Period Ended: March 31, 2020 ☐ Transition Report Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 For The Transition Period From to Commission File Number: 000-29621 XSUNX, INC. (Exact nam |
|
| May 14, 2020 |
Exhibit 10.1 STOCK Purchase Agreement This Stock Purchase Agreement (the “Agreement”) is made and entered into as of the March 18, 2020 by XsunX, Inc., a Colorado corporation (“XsunX”), which has a mailing address of 65 Enterprise, Aliso Viejo, California 92656, Tom Djokovich, an individual that owns 100% of XsunX’s outstanding Series A Preferred Stock (“Djokovich” or “Seller”), and TN3, LLC, a Wy |
|
| May 13, 2020 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 14F-1/A INFORMATION STATEMENT PURSUANT TO SECTION 14(f) OF THE SECURITIES EXCHANGE ACT OF 1934 AND RULE 14f-1 THEREUNDER XSUNX, INC. (Exact name of registrant as specified in its corporate charter) Commission File No.: 000-29621 Colorado 84-1384159 (State or other jurisdiction of incorporation or organization) (I.R.S. |
|
| May 13, 2020 |
65 Enterprise, Aliso Viejo, CA 92656 VIA EDGAR May 13, 2020 Division of Corporation Finance U. |
|
| May 11, 2020 |
May 8, 2020 Tom Djokovich President and Chief Executive Officer XsunX, Inc. 65 Enterprise Aliso Viejo, CA 92656 Re: XsunX, Inc. Schedule 14F-1 Filed May 1, 2020 File No. 005-78302 Dear Mr. Djokovich: We have reviewed the above-captioned filing and have the following comments. In some of our comments, we may ask you to provide us with information so we may better understand the disclosure. Please r |
|
| May 11, 2020 |
May 8, 2020 Tom Djokovich President and Chief Executive Officer XsunX, Inc. 65 Enterprise Aliso Viejo, CA 92656 Re: XsunX, Inc. Schedule 14F-1 Filed May 1, 2020 File No. 005-78302 Dear Mr. Djokovich: We have reviewed the above-captioned filing and have the following comments. In some of our comments, we may ask you to provide us with information so we may better understand the disclosure. Please r |
|
| May 1, 2020 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 14F-1 INFORMATION STATEMENT PURSUANT TO SECTION 14(f) OF THE SECURITIES EXCHANGE ACT OF 1934 AND RULE 14f-1 THEREUNDER XSUNX, INC. (Exact name of registrant as specified in its corporate charter) Commission File No.: 000-29621 Colorado 84-1384159 (State or other jurisdiction of incorporation or organization) (I.R.S. E |
|
| March 24, 2020 |
Entry into a Material Definitive Agreement, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): March 18, 2020 XSUNX, INC. (Exact name of registrant as specified in its charter) Colorado 000-29621 84-1384159 (State or other jurisdiction of incorporation) (Commission File Number) |
|
| January 24, 2020 |
XSNX / XsunX, Inc. 10-Q - Quarterly Report - FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ Quarterly Report Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 For The Quarterly Period Ended: December 31, 2019 ☐ Transition Report Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 For The Transition Period From to Commission File Number: 000-29621 XSUNX, INC. (Exact |
|
| December 20, 2019 |
XSNX / XsunX, Inc. 10-K - Annual Report - FORM 10-K UNITED STATES SECURITIES EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K ☒ ANNUAL REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE FISCAL YEAR ENDED SEPTEMBER 30, 2019 ☐ TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE TRANSITION PERIOD FROM TO Commission File Number 000-29621 XSUNX, INC. (Exact Name of Registrant as Spe |
|
| November 18, 2019 |
Letter from Liggett & Webb, P.A. dated November 18, 2019 Exhibit 16.1 November 18, 2019 U.S. Securities and Exchange Commission 100 F. Street Washington, DC 20549 – 7561 Ladies and Gentlemen: Re: XsunX, Inc. Commission File No. 000-29621 We have read the statements of XsunX, Inc. pertaining to our firm included in Item 4.01 of the Form 8-K dated November 18, 2019 and are in agreement with the statements contained in that document pertaining to our firm. |
|
| November 18, 2019 |
Financial Statements and Exhibits, Changes in Registrant's Certifying Accountant UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 18, 2019 XSUNX, INC. (Exact name of registrant as specified in its charter) Colorado 000-29621 84-1384159 (State or other jurisdiction of incorporation) (Commission File Numb |
|
| August 19, 2019 |
XSNX / XsunX, Inc. 10-Q - Quarterly Report - FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ Quarterly Report Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 For The Quarterly Period Ended: June 30, 2019 ☐ Transition Report Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 For The Transition Period From to Commission File Number: 000-29621 XSUNX, INC. (Exact name |
|
| August 14, 2019 |
XSNX / XsunX, Inc. NT 10-Q - - FORM NT 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 SEC FILE NUMBER 000-29621 NOTIFICATION OF LATE FILING (Check one): ☐ Form 10-K ☐ Form 20-F ☐ Form 11-K ☒ Form 10-Q ☐ Form 10-D ☐ Form N-SAR ☐ Form N-CSR For Period Ended: June 30, 2019 ☐ Transition Report on Form 10-K ☐ Transition Report on Form 20-F ☐ Transition Report on Form 11-K ☐ Transition Report on Form 10-Q |
|
| May 14, 2019 |
XSNX / XsunX, Inc. 10-Q Quarterly Report FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ Quarterly Report Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 For The Quarterly Period Ended: March 31, 2019 ☐ Transition Report Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 For The Transition Period From to Commission File Number: 000-29621 XSUNX, INC. (Exact nam |
|
| February 1, 2019 |
XSNX / XsunX, Inc. FORM 10-Q (Quarterly Report) UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ Quarterly Report Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 For The Quarterly Period Ended: December 31, 2018 ☐ Transition Report Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 For The Transition Period From to Commission File Number: 000-29621 XSUNX, INC. (Exact |
|
| January 7, 2019 |
XSNX / XsunX, Inc. FORM 10-K (Annual Report) UNITED STATES SECURITIES EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K ☒ ANNUAL REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE FISCAL YEAR ENDED SEPTEMBER 30, 2018 ☐ TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE TRANSITION PERIOD FROM TO Commission File Number 000-29621 XSUNX, INC. (Exact Name of Registrant as Spe |
|
| January 7, 2019 |
Exhibit 10.11 Notice of Extended Maturity Date The Convertible Promissory Note between XsunX, Inc. (the “Borrower”) and (the “Lender”), executed and effective on May 12, 2017 (the “Note”) had an initial Maturity Date of May 12, 2018. The Lender and Borrower hereby agree to extend the Maturity Date, and the Note Amount shall be payable upon demand, but in no event later than sixty (60) months from |
|
| December 28, 2018 |
XSNX / XsunX, Inc. FORM NT 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 OMB APPROVAL OMB Number: 3235-0058 Expires: December 31, 2018 Estimated average burden hours per response 2.50 FORM 12b-25 SEC FILE NUMBER 000-29621 NOTIFICATION OF LATE FILING CUSIP NUMBER (Check one): ☒ Form 10-K ☐ Form 20-F ☐ Form 11-K ☐ Form 10-Q ☐ Form 10-D ☐ Form N-SAR ☐ Form N-CSR For Period Ended: September 30, 2018 ☐ |
|
| August 14, 2018 |
Exhibit 10.2 SECURITIES PURCHASE AGREEMENT This SECURITIES PURCHASE AGREEMENT (the “Agreement”), dated as of August 6, 2018, by and between XSUNX, INC., a Colorado corporation, with its address at 65 Enterprise, Aliso Viejo, CA 92656 (the “Company”), and , a Virginia corporation, with its address at (the “Buyer”). WHEREAS: A. The Company and the Buyer are executing and delivering this Agreement in |
|
| August 14, 2018 |
XSNX / XsunX, Inc. FORM 10-Q (Quarterly Report) UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ Quarterly Report Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 For The Quarterly Period Ended: June 30, 2018 ☐ Transition Report Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 For The Transition Period From to Commission File Number: 000-29621 XSUNX, INC. (Exact name |
|
| August 14, 2018 |
Exhibit 10.1 NEITHER THE ISSUANCE AND SALE OF THE SECURITIES REPRESENTED BY THIS CERTIFICATE NOR THE SECURITIES INTO WHICH THESE SECURITIES ARE CONVERTIBLE HAVE BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR APPLICABLE STATE SECURITIES LAWS. THE SECURITIES MAY NOT BE OFFERED FOR SALE, SOLD, TRANSFERRED OR ASSIGNED IN THE ABSENCE OF (A) AN EFFECTIVE REGISTRATION STATEMENT FOR THE |
|
| May 21, 2018 |
XSNX / XsunX, Inc. 10-Q (Quarterly Report) UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ Quarterly Report Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 For The Quarterly Period Ended: March 31, 2018 ☐ Transition Report Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 For The Transition Period From to Commission File Number: 000-29621 XSUNX, INC. (Exact nam |
|
| May 15, 2018 |
SEC FILE NUMBER 000-29621 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 12b-25 NOTIFICATION OF LATE FILING ☐ Form 10-K ☐ Form 20-F ☐ Form 11-K ☒ Form 10-Q ☐ Form N-SAR ☐ Form N-CSR For the Period Ended: March 31, 2018 ☐ Transition Report on Form 10-K ☐ Transition Report on Form 10-Q ☐ Transition Report on Form 20-F ☐ Transition Report on Form N-SAR ☐ Transition Report on Form 11-K For the Transition Period Ended: Nothing in this Form shall be construed to imply that the Commission has verified any information contained herein. |
|
| May 14, 2018 |
Form of Securities Purchase Agreement Exhibit 10.2 SECURITIES PURCHASE AGREEMENT This SECURITIES PURCHASE AGREEMENT (the “Agreement”), dated as of May 7, 2018, by and between XSUNX, INC., a Colorado corporation, with its address at 65 Enterprise, Aliso Viejo, CA 92656 (the “Company”), and , a Virginia corporation, with its address at (the “Buyer”). WHEREAS: A. The Company and the Buyer are executing and delivering this Agreement in re |
|
| May 14, 2018 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 9, 2018 XSUNX, INC. (Exact name of registrant as specified in its charter) Colorado 000-29621 84-1384159 (State or other jurisdiction of incorporation) (Commission File Number) (I |
|
| May 14, 2018 |
Exhibit 10.1 NEITHER THE ISSUANCE AND SALE OF THE SECURITIES REPRESENTED BY THIS CERTIFICATE NOR THE SECURITIES INTO WHICH THESE SECURITIES ARE CONVERTIBLE HAVE BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR APPLICABLE STATE SECURITIES LAWS. THE SECURITIES MAY NOT BE OFFERED FOR SALE, SOLD, TRANSFERRED OR ASSIGNED IN THE ABSENCE OF (A) AN EFFECTIVE REGISTRATION STATEMENT FOR THE |
|
| February 14, 2018 |
XSNX / XsunX, Inc. / GEMINI MASTER FUND LTD - AMENDMENT NO. 4 TO SCHEDULE 13G Passive Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 13G (Rule 13d-102) Information to be Included in Statements Filed Pursuant to Rules 13d-1(b), (c) and (d) and Amendments Thereto Filed Pursuant to Rule 13d-2 (AMENDMENT NO. 4)* XsunX, Inc. (Name of Issuer) Common Stock, no par value (Title of Class of Securities) 98385L102 (CUSIP Number) December 31, 2017 (Date of Eve |
|
| February 12, 2018 |
XSNX / XsunX, Inc. 10-Q (Quarterly Report) UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ Quarterly Report Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 For The Quarterly Period Ended: December 31, 2017 ☐ Transition Report Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 For The Transition Period From to Commission File Number: 000-29621 XSUNX, INC. (Exact |
|
| January 17, 2018 |
Exhibit 99.1 XsunX Expands Direct Marketing Efforts to Include California Cannabis Industry Company set to promote its solar + energy storage solutions to over 1000 California based cannabis operations ALISO VIEJO, CA? January 17, 2018 - XsunX, Inc. ( OTC: XSNX ) , a leading commercial solar and energy storage technologies provider, announced today that with the passage of California?s Prop. 64 le |
|
| January 17, 2018 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): January 16, 2018 XSUNX, INC. (Exact name of registrant as specified in its charter) Colorado 000-29621 84-1384159 (State or other jurisdiction of incorporation) (Commission File Numbe |
|
| January 17, 2018 |
Form of Securities Purchase Agreement Exhibit 10.2 SECURITIES PURCHASE AGREEMENT This SECURITIES PURCHASE AGREEMENT (the ?Agreement?), dated as of January 11, 2018, by and between XSUNX, INC., a Colorado corporation, with its address at 65 Enterprise, Aliso Viejo, CA 92656 (the ?Company?), and , a Virginia corporation, with its address at (the ?Buyer?). WHEREAS: A. The Company and the Buyer are executing and delivering this Agreement |
|
| January 17, 2018 |
Form of 10% Convertible Promissory Note Exhibit 10.1 NEITHER THE ISSUANCE AND SALE OF THE SECURITIES REPRESENTED BY THIS CERTIFICATE NOR THE SECURITIES INTO WHICH THESE SECURITIES ARE CONVERTIBLE HAVE BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR APPLICABLE STATE SECURITIES LAWS. THE SECURITIES MAY NOT BE OFFERED FOR SALE, SOLD, TRANSFERRED OR ASSIGNED IN THE ABSENCE OF (A) AN EFFECTIVE REGISTRATION STATEMENT FOR THE |
|
| December 21, 2017 |
UNITED STATES SECURITIES EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K ☒ ANNUAL REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE FISCAL YEAR ENDED SEPTEMBER 30, 2017 ☐ TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE TRANSITION PERIOD FROM TO Commission File Number 000-29621 XSUNX, INC. (Exact Name of Registrant as Spe |
|
| August 14, 2017 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ Quarterly Report Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 For The Quarterly Period Ended: June 30, 2017 ☐ Transition Report Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 For The Transition Period From to Commission File Number: 000-29621 XSUNX, INC. (Exact name |
|
| May 15, 2017 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ Quarterly Report Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 For The Quarterly Period Ended: March 31, 2017 ☐ Transition Report Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 For The Transition Period From to Commission File Number: 000-29621 XSUNX, INC. (Exact nam |
|
| May 15, 2017 |
EXHIBIT 10.5 CONVERTIBLE PROMISSORY NOTE $150,000 FOR VALUE RECEIVED, XsunX, Inc., a Colorado corporation, (the “Borrower”) with approximately 967,714,645 shares of common stock issued and outstanding, promises to pay to , a Nevada limited liability company, or its assignees (the “Lender”) the Principal Sum along with the Interest and any other fees according to the terms herein (this “Note”). Thi |
|
| February 27, 2017 |
Mail Stop 4631 February 27, 2017 Via E-mail Mr. Tom Djokovich Chief Executive Officer and Principal Accounting Officer XsunX, Inc. 65 Enterprise Aliso Viejo, CA 92656 Re: XsunX, Inc. Form 10-K for Fiscal Year Ended September 30, 2016 Filed December 14, 2016 File No. 0-29621 Dear Mr. Djokovich: We have completed our review of your filing. We remind you that the company and its management are respon |
|
| February 21, 2017 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ Quarterly Report Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 For The Quarterly Period Ended: December 31, 2016 ☐ Transition Report Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 For The Transition Period From to Commission File Number: 000-29621 XSUNX, INC. (Exact |
|
| February 17, 2017 |
UNITED STATES SECURITIES EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K/A (Amendment No.1) ANNUAL REPORT PURSUANT TO THE SECURITIES EXCHANGE ACT OF 1934 For the Fiscal Year Ended September 30, 2016 Commission File Number 000-29621 XSUNX, INC. (Exact Name of Registrant as Specified in Its Charter) Colorado 84-1384159 (State of Incorporation) (I.R.S. Employer Identification No.) 65 Enterprise, |
|
| February 17, 2017 |
65 Enterprise, Aliso Viejo, CA 92656 Mail Stop 4631 United States Securities and Exchange Commission Washington, D. |
|
| February 17, 2017 |
UNITED STATES SECURITIES EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K/A (Amendment No.1) ANNUAL REPORT PURSUANT TO THE SECURITIES EXCHANGE ACT OF 1934 For the Fiscal Year Ended September 30, 2016 Commission File Number 000-29621 XSUNX, INC. (Exact Name of Registrant as Specified in Its Charter) Colorado 84-1384159 (State of Incorporation) (I.R.S. Employer Identification No.) 65 Enterprise, |
|
| February 14, 2017 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 12b-25 NOTIFICATION OF LATE FILING ? Form 10-K ? Form 20-F ? Form 11-K ? Form 10-Q ? Form N-SAR ? Form N-CSR For the Period Ended: December 31, 2016 ? Transition Report on Form 10-K ? Transition Report on Form 10-Q ? Transition Report on Form 20-F ? Transition Report on Form N-SAR ? Transition Report on Form 11-K For the Transition Period Ended: Nothing in this Form shall be construed to imply that the Commission has verified any information contained herein. |
|
| February 14, 2017 |
XSNX / XsunX, Inc. / GEMINI MASTER FUND LTD - AMENDMENT NO. 3 TO SCHEDULE 13G Passive Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 13G (Rule 13d-102) Information to be Included in Statements Filed Pursuant to Rules 13d-1(b), (c) and (d) and Amendments Thereto Filed Pursuant to Rule 13d-2 (AMENDMENT NO. 3)* XsunX, Inc. (Name of Issuer) Common Stock, no par value (Title of Class of Securities) 98385L102 (CUSIP Number) December 31, 2016 (Date of Eve |
|
| February 9, 2017 |
Mail Stop 4631 February 9, 2017 Via E-mail Mr. Tom Djokovich Chief Executive Officer and Principal Accounting Officer XsunX, Inc. 65 Enterprise Aliso Viejo, CA 92656 Re: XsunX, Inc. Form 10-K for Fiscal Year Ended September 30, 2016 Filed December 14, 2016 File No. 0-29621 Dear Mr. Djokovich: We have reviewed your filing and have the following comments. In some of our comments, we may ask you to p |
|
| January 30, 2017 |
Letter from Haynie & Company dated January 26, 2017 Exhibit 16.1 January 26, 2017 U.S. Securities and Exchange Commission 100 F. Street Washington, DC 20549 ? 7561 Ladies and Gentlemen: Re: XsunX, Inc. Commission File No. 000-29621 We have read the statements of XsunX, Inc. pertaining to our firm included in Item 4.01 of the Form 8-K dated January 26, 2017 and are in agreement with the statements contained in that document pertaining to our firm. S |
|
| January 30, 2017 |
Financial Statements and Exhibits, Changes in Registrant's Certifying Accountant UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): January 26, 2017 XSUNX, INC. (Exact name of registrant as specified in its charter) Colorado 000-29621 84-1384159 (State or other jurisdiction of incorporation) (Commission File Numbe |
|
| December 14, 2016 |
UNITED STATES SECURITIES EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K ANNUAL REPORT PURSUANT TO THE SECURITIES EXCHANGE ACT OF 1934 For the Fiscal Year Ended September 30, 2016 Commission File Number 000-29621 XSUNX, INC. (Exact Name of Registrant as Specified in Its Charter) Colorado 84-1384159 (State of Incorporation) (I.R.S. Employer Identification No.) 65 Enterprise, Aliso Viejo, CA 92 |
|
| December 14, 2016 |
Exhibit 10.7 ADDENDUM TO CONVERTIBLE PROMISSORY NOTE This Addendum to Convertible Promissory Note (the ?Addendum?) is made as of this 13 day of October, 2016 by and between XsunX, Inc., a Colorado corporation (the ?Borrower?), and Lender, the holder of a convertible promissory note pursuant to that certain Convertible Promissory Note, dated November 20, 2014 (the ?Lender?), with respect to the fol |
|
| August 15, 2016 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ Quarterly Report Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 For The Quarterly Period Ended: June 30, 2016 ☐ Transition Report Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 For The Transition Period From to Commission File Number: 000-29621 XSUNX, INC. (Exact name |
|
| August 15, 2016 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ Quarterly Report Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 For The Quarterly Period Ended: June 30, 2016 ☐ Transition Report Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 For The Transition Period From to Commission File Number: 000-29621 XSUNX, INC. (Exact name |
|
| May 16, 2016 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ Quarterly Report Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 For The Quarterly Period Ended: March 31, 2016 ☐ Transition Report Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 For The Transition Period From to Commission File Number: 000-29621 XSUNX, INC. (Exact nam |
|
| February 12, 2016 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q x Quarterly Report Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 For The Quarterly Period Ended: December 31, 2015 o Transition Report Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 For The Transition Period From to Commission File Number: 000-29621 XSUNX, INC. (Exact |
|
| February 12, 2016 |
XSNX / XsunX, Inc. / GEMINI MASTER FUND LTD - AMENDMENT NO. 2 TO SCHEDULE 13G Passive Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 13G (Rule 13d-102) Information to be Included in Statements Filed Pursuant to Rules 13d-1(b), (c) and (d) and Amendments Thereto Filed Pursuant to Rule 13d-2 (AMENDMENT NO. 2)* XsunX, Inc. (Name of Issuer) Common Stock, no par value (Title of Class of Securities) 98385L102 (CUSIP Number) December 31, 2015 (Date of Eve |
|
| January 26, 2016 |
Letter from HJ Associates & Consultants, LLP dated January 26, 2016 ex16-1.htm Exhibit 16.1 January 26, 2016 U.S. Securities and Exchange Commission 100 F. Street Washington, DC 20549 ? 7561 Ladies and Gentlemen: Re: XsunX, Inc. Commission File No. 000-29621 We have read the statements of XsunX, Inc. pertaining to our firm included in Item 4.01 of the Form 8-K dated January 18, 2016 and are in agreement with the statements contained in that document pertaining to |
